A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series
Neurological symptoms in COVID-19 patients can also be found in the pediatric population, but they are usually described as mild symptoms. Herein, we described a case series of four pediatric patients with severe and highly heterogeneous central and peripheral nervous system manifestations. The obje...
Gespeichert in:
Veröffentlicht in: | Journal of neurovirology 2021-10, Vol.27 (5), p.782-786 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Neurological symptoms in COVID-19 patients can also be found in the pediatric population, but they are usually described as mild symptoms. Herein, we described a case series of four pediatric patients with severe and highly heterogeneous central and peripheral nervous system manifestations. The objective was to report neurological manifestations of COVID-19 in children and adolescents. The design is case series. The participants are four children and adolescents with confirmed COVID-19. The main outcome and measures are as follows: Clinical data were gathered from electronic medical records, and data of all neurologic symptoms were checked by a trained neurologist. We reported four pediatric patients with COVID-19 and different neurologic symptoms.
Case 1
was a 16-year-old girl with a sensory and motor polyradiculopathy with RT-qPCR for COVID-19 and dengue both detected in CSF that improved after appropriate treatment.
Case 2
was a 15-year-old boy with Guillain–Barre syndrome and had good response after using human immunoglobulin.
Case 3
was a 5-year-old girl with acute intracranial hypertension that improved after going through lumbar puncture and using acetazolamide.
Case 4
was a 2-month-old male infant with focal epileptic seizures that recovered after antiepileptic treatment. We highlight the need to consider different neurologic manifestations as part of the COVID-19 clinical spectrum. |
---|---|
ISSN: | 1355-0284 1538-2443 |
DOI: | 10.1007/s13365-021-01004-9 |